TPG and Temasek have sold nearly 13% of Dr Agarwals Health Care in open-market transactions worth ₹2,008 crore, even as the company reports a strong quarter and rapid expansion, signalling strategic repositioning amid positive growth prospects.
TPG and Temasek have pared back their combined holding in Dr Agarwals Health Care by selling nearly 13% of the eye care chain in open-market transactions worth about ₹2,008 crore, according to bulk deal data on the National Stock Exchange and reporting by The Hindu BusinessLine. The sale, executed on Wednesday, involved more than 4 crore shares priced between ₹501.03 and ₹501.54 each.
The two investors trimmed their stakes through affiliates. TPG, via Hyperion Investments Pte Ltd, reduced its holding to 15.47% from 23.09%, while Temasek, through Claymore Investments (Mauritius) Pte Ltd, cut its stake to 5.17% from 10.19%. Even after the disposal, the pair remained the company’s largest public shareholders, BusinessLine reported.
The buyers included ICICI Prudential Mutual Fund, Invesco Mutual Fund, Polar Capital and Allianz Global Investors, which together picked up more than 1.51 crore shares, or close to a 5% stake, for about ₹761.60 crore. The identity of other buyers was not fully visible in NSE data. Shares of Dr Agarwals Health Care fell nearly 6% to close at ₹511.
The stake sale came shortly after the company reported a strong first quarter, with consolidated profit after tax rising 44.6% year on year to ₹55.02 crore and revenue increasing 26% to ₹614.02 crore. The chain said it had expanded to 304 facilities across 10 countries and completed its biggest quarterly expansion of surgical centres. Earlier investor materials showed continued momentum through FY26, with revenue, EBITDA and profit all rising sharply as the network expanded and surgery volumes increased.
Disclaimer: This article is intended to inform and educate, not to recommend or endorse any financial product, investment or strategy. Please consider your own financial circumstances and seek professional advice where appropriate before making financial decisions.
